Skip to main content
Enwei Pharmaceutical Co., Ltd. logo

Enwei Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 301331 ISIN · CNE100005LC7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 427 across all filing types
Latest filing 2025-06-03 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 301331

About Enwei Pharmaceutical Co., Ltd.

https://www.enwei.com.cn

Enwei Pharmaceutical Co., Ltd. focuses on the research, development, and manufacturing of medicinal products, specializing in Chinese patent medicines and chemical drugs. The company is primarily known for its gynecological health solutions, most notably the Jie Er Yin brand. Its diverse product range covers therapeutic categories such as pediatrics, dermatology, and respiratory care. By combining traditional Chinese medicine with modern pharmacological standards, the company produces various dosage forms including lotions, capsules, and granules. The organization emphasizes clinical efficacy and quality management, targeting a wide range of healthcare needs through ongoing innovation in formulation and drug delivery systems.

Recent filings

Filing Released Lang Actions
关于持股5%以上股东部分股份质押及解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement from a company regarding the pledge and release of shares held by shareholders owning more than 5% of the company's stock. It details the number of shares pledged, released, and the related terms, including the shareholders involved and the impact on the company's operations and governance. The document is a regulatory disclosure about share pledging activities by major shareholders, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis but focuses on share pledge status and related shareholder information. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels or related shareholder share transactions such as pledges.
2025-06-03 Chinese
2024年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of the 2024 annual dividend distribution plan by 恩威医药股份有限公司. It details the dividend amount per share, the record date, the ex-dividend date, the shareholders entitled to the dividend, and other related procedural information. It also references the approval of the dividend plan at the 2024 annual shareholders meeting and provides specifics on the dividend payment method and tax treatment. The document is relatively short (3098 characters) and focuses on the dividend distribution details rather than presenting a full financial report or earnings release. Therefore, it fits the category of a Notice of Dividend Amount (DIV), which covers announcements of dividend amounts, payment dates, and details for shareholders.
2025-05-20 Chinese
关于选举职工代表董事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election of an employee representative director to the company's board. It discusses governance structure changes, compliance with company law and listing rules, and provides a biography of the newly elected director. There is no financial data, no mention of financial results, no audit information, no voting results from a general meeting, and no reference to a report publication. The content focuses on board composition and governance matters. Therefore, the document fits best under Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2025-05-16 Chinese
关于持股5%以上股东部分股份质押及解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement from a company disclosing details about share pledges and pledge releases by shareholders holding more than 5% of the company's shares. It includes detailed tables of pledged shares, pledge start and end dates, pledgees, and explanations about the impact of these pledges on the company. There is no financial statement, earnings data, or management discussion of financial results. The document is not an annual or interim report, nor is it a call transcript or governance report. It is a regulatory announcement about significant shareholder share pledges and releases, which fits the category of Major Shareholding Notification (MRQ). The document length is 3519 characters, which is consistent with a detailed announcement rather than a full report. Therefore, the appropriate classification is MRQ with high confidence.
2025-05-16 Chinese
2024年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as the "2024 Annual General Meeting Resolution Announcement" of Enwei Pharmaceutical Co., Ltd. It details the convening and attendance of the 2024 Annual General Meeting (AGM), the voting results on various proposals including the 2024 annual report, financial statements, profit distribution plan, and other corporate governance matters. The document includes detailed voting outcomes and legal opinions confirming the validity of the meeting and resolutions. It does not contain the full annual report or financial statements themselves but rather the official announcement of the AGM resolutions and voting results. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 5472 characters, which is sufficient for a detailed voting results announcement but not a full report. Therefore, the correct classification is DVA with high confidence.
2025-05-12 Chinese
北京金杜（成都）律师事务所关于恩威医药股份有限公司2024年年度股东大会之法律意见书
Regulatory Filings
2025-05-12 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.